Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Phototherapy for Vitiligo
Description
The presentation underscores the significance of phototherapy in treating vitiligo, emphasizing its role in stimulating melanocyte repigmentation alongside immunosuppressive therapies. The speaker notes that both the removal of T cells and the stimulation of melanocytes are essential for effective treatment, advising patients on the necessity of combining therapies rather than solely relying on topical agents. Various treatment options were discussed, including antioxidants, corticosteroids, and newer agents like ruxolitinib combined with phototherapy, which demonstrate enhanced results. The importance of setting realistic expectations and monitoring progress through photographs is highlighted, as it helps both doctors and patients see improvements over time. Phototherapy methods vary, with narrowband UVB being a prevalent choice, as well as home phototherapy options, which are posited as cost-effective and effective alternatives. Key factors influencing treatment success include the patient's age, skin type, and the duration and location of vitiligo. The speaker encourages early intervention with phototherapy in pediatric patients and highlights that improved outcomes are commonly seen in patients who diligently follow phototherapy regimens. The overarching theme emphasizes the multifaceted approach to vitiligo treatment, advocating for a combination of phototherapy, topical medications, and patient education to optimize results.
View moreConclusions
- Phototherapy is a critical component in the treatment of vitiligo, particularly for stimulating melanocyte activity.
- A combination of treatments improves efficacy, with topical and oral therapies yielding better results when paired with phototherapy.
- Successful treatment outcomes are generally defined as over 75% repigmentation, although achieving 100% repigmentation is rare.
- Factors influencing treatment success include patient age, skin type, duration of vitiligo, and the location of lesions.
- Younger patients with darker skin types and shorter durations of vitiligo experience better prognosis.
- Visible areas are prioritized in treatment, and patient expectations must be managed effectively.
- Phototherapy protocols should include gradual dosing and consideration of photoadaptation to minimize toxicity.
- Home phototherapy is an effective, cost-efficient treatment option that can enhance patient compliance.
- Regular monitoring through photographic documentation is essential for assessing treatment progress.
- Safety data suggest no significant increased risk of skin cancer from phototherapy compared to untreated populations.
- Sosa JJ, Pandya AG, et al, JAAD 2015
- Yones SS, Hawk JLM, et al, Arch Dermatol 2007; 143:578-584
- Narayan VS, et al, JEADV 2023
- Dillon JC, Pandya AG, et al, Photodermatol, Photoimmunol, Photomed 2017;33:282-283
- Zhang L, et al, Photodermatology 2019; 35:261-267
- Garza-Mayers AC, et al, JAAD 2023
- Wu YH, et al, Clin Exp Dermatol 2022
- Amit G. Pandya, MD and Samia M. Esmat, MD, J Am Acad Dermatol 2017; 76:879-888
- Hong J, et al, Ped Dermatol 2019;36:e53-e55
- Hexsel CL, Lim H, Hamzavi I, et al, Br J Dermal 2009; 160:534-539
- Mehta C, et al, Photodermatology 2019; 35:318-321
- Yamaguchi Y, et al, JAAD 2024
- Seneschal J, et al, JAMA Dermatol 2025
- Hu Z, et al, Pigm Cell 2025